Pharmanutra S.p.A. (BIT:PHN)

Market Cap	458.55M
Revenue (ttm)	118.93M
Net Income (ttm)	16.41M
Shares Out	9.60M
EPS (ttm)	1.71
PE Ratio	27.95
Forward PE	21.00
Dividend	1.00 (2.09%)
Ex-Dividend Date	May 5, 2025

Volume	1,466
Average Volume	4,393
Open	47.80
Previous Close	47.75
Day's Range	47.20 - 47.90
52-Week Range	45.20 - 61.20
Beta	0.30
RSI	52.88
Earnings Date	Sep 8, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 118
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.